1. Home
  2. BIVI vs INLF Comparison

BIVI vs INLF Comparison

Compare BIVI & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • INLF
  • Stock Information
  • Founded
  • BIVI 2013
  • INLF 2016
  • Country
  • BIVI United States
  • INLF China
  • Employees
  • BIVI N/A
  • INLF N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • INLF Industrial Machinery/Components
  • Sector
  • BIVI Health Care
  • INLF Industrials
  • Exchange
  • BIVI Nasdaq
  • INLF Nasdaq
  • Market Cap
  • BIVI 18.6M
  • INLF 16.2M
  • IPO Year
  • BIVI N/A
  • INLF 2025
  • Fundamental
  • Price
  • BIVI $0.97
  • INLF $1.12
  • Analyst Decision
  • BIVI
  • INLF
  • Analyst Count
  • BIVI 0
  • INLF 0
  • Target Price
  • BIVI N/A
  • INLF N/A
  • AVG Volume (30 Days)
  • BIVI 210.2K
  • INLF 3.6M
  • Earning Date
  • BIVI 05-12-2025
  • INLF 01-01-0001
  • Dividend Yield
  • BIVI N/A
  • INLF N/A
  • EPS Growth
  • BIVI N/A
  • INLF 18.78
  • EPS
  • BIVI N/A
  • INLF 0.13
  • Revenue
  • BIVI N/A
  • INLF $15,796,983.00
  • Revenue This Year
  • BIVI N/A
  • INLF N/A
  • Revenue Next Year
  • BIVI N/A
  • INLF N/A
  • P/E Ratio
  • BIVI N/A
  • INLF $8.71
  • Revenue Growth
  • BIVI N/A
  • INLF 25.27
  • 52 Week Low
  • BIVI $0.62
  • INLF $0.77
  • 52 Week High
  • BIVI $7.50
  • INLF $21.00
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 42.25
  • INLF N/A
  • Support Level
  • BIVI $0.88
  • INLF N/A
  • Resistance Level
  • BIVI $1.03
  • INLF N/A
  • Average True Range (ATR)
  • BIVI 0.07
  • INLF 0.00
  • MACD
  • BIVI -0.02
  • INLF 0.00
  • Stochastic Oscillator
  • BIVI 23.97
  • INLF 0.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About INLF INLIF LIMITED Ordinary Shares

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

Share on Social Networks: